# OPVEE
> **NDA217470** · New Drug Application · Sponsor: INDIVIOR · Approved 2023-05-22
## Drug
- **FDA Application Number:** NDA217470
- **Application type:** New Drug Application
- **Brand name:** OPVEE
- **Generic name:** NALMEFENE HYDROCHLORIDE
- **Active ingredients:** NALMEFENE HYDROCHLORIDE
- **Dosage form:** SPRAY
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** INDIVIOR
- **Manufacturer:** Indivior Inc.
- **First approval:** 2023-05-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217470)
---
*MORVS · CC0 1.0*